Department of Surgical Oncology
Yaobang Liu has not added Biography.
If you are Yaobang Liu and would like to personalize this page please email our Author Liaison for assistance.
[Expression of superoxide dismutase 2 in breast cancer and its clinical significance].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University Aug, 2020 | Pubmed ID: 32895185
MicroRNA-1297 downregulation inhibits breast cancer cell epithelial-mesenchymal transition and proliferation in a FA2H-dependent manner.
Oncology letters Dec, 2020 | Pubmed ID: 33014155
Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
Breast cancer (Tokyo, Japan) Mar, 2021 | Pubmed ID: 33108608
DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer.
Cancer cell international Mar, 2022 | Pubmed ID: 35255904
Exosomes Derived from Tumor Cells Initiate Breast Cancer Cell Metastasis and Chemoresistance through a MALAT1-Dependent Mechanism.
Journal of oncology , 2022 | Pubmed ID: 35813865
Watson for oncology decision system for treatment consistency study in breast cancer.
Clinical and experimental medicine Sep, 2023 | Pubmed ID: 36138331
HINT3 suppresses AKT/mTOR signaling pathway activity during breast cancer tumorigenesis through PTEN transcriptional activation.
International journal of molecular medicine Jul, 2023 | Pubmed ID: 37203409
Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
BMC pulmonary medicine Jun, 2023 | Pubmed ID: 37308925
Knockdown of LINC00702 inhibits the growth and induces apoptosis of breast cancer through the Wnt/β-catenin pathway.
Heliyon Oct, 2023 | Pubmed ID: 37860544
Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials.
Future oncology (London, England) Oct, 2023 | Pubmed ID: 37882431
Treatment-related adverse events of antibody-drug conjugates in clinical trials: A systematic review and meta-analysis.
Cancer innovation Oct, 2023 | Pubmed ID: 38090386
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction.
American journal of clinical oncology May, 2024 | Pubmed ID: 38131531
Survival nomogram for patients with metastatic breast cancer based on the SEER database and an external validation cohort.
Cancer pathogenesis and therapy Oct, 2023 | Pubmed ID: 38327599
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients.
Breast cancer (Dove Medical Press) , 2024 | Pubmed ID: 38476641
Clinicopathological characteristics and prognostic factors in invasive micropapillary carcinoma of the breast.
Archives of medical science : AMS , 2024 | Pubmed ID: 38757040
LncRNA TCL6 regulates miR-876-5p/MYL2 axis to suppress breast cancer progression.
Translational oncology Mar, 2025 | Pubmed ID: 39874729
The RNA-binding protein LARP6 regulates the alternative splicing of related genes in MDA-MB-231 cells.
Scientific reports Mar, 2025 | Pubmed ID: 40050364
Nomogram for predicting the risk and prognosis of lung metastasis of four subtypes of breast cancer: A population-based study from SEER.
Cancer pathogenesis and therapy Mar, 2025 | Pubmed ID: 40182125
Copyright © 2025 MyJoVE Corporation. All rights reserved